Press releases – Annexin Pharmaceuticals

Approval of COVID19-study

19 January, 2022

Maastricht University Hospital receives approvals to start study with Annexin Pharmaceuticals drug candidate, ANXV, in patients with COVID19. STOCKHOLM, SWEDEN (January 19, 2022) – Annexin Pharmaceuticals AB ...

Welcome to the Annexin Pharmaceuticals AB website. In order to optimize your use of our website, we use cookies. A cookie is a text file that is stored on your computer. If you would like further information on what a cookie is, what cookies we use, what cookies are for or how to block or delete cookies, please read “About Cookies“. By continuing, you agree to our use of cookies.